Cassaday & Co Wealth Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$59K Sell
684
-5
-0.7% -$416 ﹤0.01% 585
2026
Q2
$46.4K Sell
689
-6
-0.9% -$400 ﹤0.01% 632
2026
Q1
$43.6K Buy
+695
New +$48.4K ﹤0.01% 638

Other funds holding DXCM

Cassaday & Co Wealth Management's DXCM Position: Q3 2026 in Review

Cassaday & Co Wealth Management reduced its DexCom (DXCM) stake by 0.73% in Q3 2026, selling an estimated $416 and leaving 684 shares worth $59K. The position accounts for ﹤0.01% of the portfolio, ranked #585.

Cassaday & Co Wealth Management first reported a position in DXCM in Q1 2026 and has held it in 3 quarters since. 620 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Cassaday & Co Wealth Management held 684 shares of DexCom worth $59K as of Q3 2026.
  • Cassaday & Co Wealth Management sold 5 DexCom shares in Q3 2026, an estimated $416.
  • DexCom made up ﹤0.01% of Cassaday & Co Wealth Management's portfolio in Q3 2026, its #585 holding.
  • Cassaday & Co Wealth Management first reported a position in DexCom in Q1 2026 and has held it in 3 quarters since.
  • 620 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Cassaday & Co Wealth Management's 13F filing for Q3 2026, filed 27 Oct 2026.